Fingerprint
Dive into the research topics of 'Glasdegib plus intensive/nonintensive chemotherapy in untreated acute myeloid leukemia: BRIGHT AML 1019 Phase III trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Glasdegib plus intensive/nonintensive chemotherapy in untreated acute myeloid leukemia: BRIGHT AML 1019 Phase III trials
Jorge E. Cortes, Hervé Dombret, Akil Merchant, Tetsuzo Tauchi, Christine G. Dirienzo, Barbara Sleight, Xiaoxi Zhang, Eric P. Leip, Naveed Shaik, Timothy Bell, Geoffrey Chan, Mikkael A. Sekeres
Research output: Contribution to journal › Article › peer-review
37
Scopus
citations